| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Tissue factor pathway inhibitor (TFPI) in IDDM patients with and withoutmicro- and/or macrovascular complications. |
Leurs, P.B.;Oerle, R.v.;Hamulyak, K.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1995-12-01 |
查看 |
| Apolipoproteins in hyperlipidaemic and type 2 diabetic subjects. |
Wolffenbuttel, B.H.R.;Rondas-Colbers, G.J.W.M.;Swennen, G.N.M.;Sels, J.P.; |
The Netherlands Journal of Medicine |
1996-04-01 |
查看 |
| Lipid oxidation in type 2 diabetes. |
Oranje, W.A.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1996-05-01 |
查看 |
| Shock of unknown origin--think of mastocytosis! |
Gonera, R.K.;Oranje, W.A.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-04-01 |
查看 |
| Shock of unknown origin--think of mastocytosis! |
Gonera, R.K.;Oranje, W.A.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-04-01 |
查看 |
| The effect of improved metabolic control on LDL susceptibility to oxidationin subjects with NIDDM. |
Oranje, W.A.;Rondas, G.J.W.M.;Swennen, G.N.M.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-05-01 |
查看 |
| The effect of improved metabolic control on LDL susceptibility to oxidationin subjects with NIDDM. |
Oranje, W.A.;Rondas, G.J.W.M.;Swennen, G.N.M.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-05-01 |
查看 |
| Effects of acarbose on glycaemic control in subjects with IDDM. |
Dutch IDDM Acarbose Study Group,;Sels, J.P.J.E.;Verdonk, H.E.R.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| Autoantibodies to oxidized LDL are not elevated in subjects with NIDDM. |
Oranje, W.A.;Rondas, G.J.W.M.;Swennen, G.;Jansen, H.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| In vitro anti-oxidative effects of aminoguanidine are dependent on LDLconcentration. |
Wolffenbuttel, B.H.R.;Rondas, G.J.W.M.;Oranje, W.A.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| Effects of acarbose on glycaemic control in subjects with IDDM. |
Dutch IDDM Acarbose Study Group,;Sels, J.P.J.E.;Verdonk, H.E.R.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| Autoantibodies to oxidized LDL are not elevated in subjects with NIDDM. |
Oranje, W.A.;Rondas, G.J.W.M.;Swennen, G.;Jansen, H.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| In vitro anti-oxidative effects of aminoguanidine are dependent on LDLconcentration. |
Wolffenbuttel, B.H.R.;Rondas, G.J.W.M.;Oranje, W.A.; |
The Netherlands Journal of Medicine |
1997-06-01 |
查看 |
| Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin,in comparison with simvastatin and pravastatin, in subjects withhypercholesterolemia |
Wolffenbuttel, B.H.R.;Mahla, G.;Muller, D.;Pentrup, A.;Black, D.M.; |
The Netherlands Journal of Medicine |
1998-04-01 |
查看 |
| Consequences of long-term hyperparathyroidism |
Graal, M.B.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1998-07-01 |
查看 |
| Lipid peroxidation in type 2 diabetes: relationship with macrovasculardisease? |
Oranje, W.A.;Rondas-Colbers, G.J.W.M.;Swennen, G.N.M.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1998-08-01 |
查看 |
| Prognostic factors for successful insulin therapy in subjects with type 2diabetes |
Wolffenbuttel, B.H.R.;Sels, J.-P.J.E.;Rondas-Colbers, G.J.W.M.;Menheere, P.P.C.A.; |
The Netherlands Journal of Medicine |
1999-02-01 |
查看 |
| Repaglinide - a new compound for the treatment of patients with type 2diabetes |
Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
1999-11-01 |
查看 |
| Pitfall of the accessory spleen |
Sels, J.P.J.E.;Wouters, R.M.M.E.;Lamers, R.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
2000-04-01 |
查看 |
| Clinical experience with Sandostatin LAR^(R) in patients with acromegaly |
Heijckmann, C.A.;Menheere, P.P.C.A.;Sels, J.-P.J.E.;Beuls, E.A.M.;Wolffenbuttel, B.H.R.; |
The Netherlands Journal of Medicine |
2001-12-01 |
查看 |
|
|
